Skip to main content
. 2019 Nov 22;10:820. doi: 10.3389/fendo.2019.00820

Figure 4.

Figure 4

Cox proportional hazard models for decrease in eGFR over 40% in patients receiving sodium–glucose cotransporter 2 inhibitors and other drugs. The probability of a decrease in eGFR over 40% is shown for empagliflozin 10 mg/tab, empagliflozin 25 mg/tab, and dapagliflozin 10 mg/tab users vs. non-users in different renal function subgroups. eGFR, estimated glomerular filtration rate.